The Journal of Neuroscience, December 1, 2000, 20(23):8659-8666
Decreases in Endogenous Opioid Peptides in the Rat
Medullo-Coerulear Pathway after Chronic Morphine Treatment
Elisabeth J.
Van Bockstaele1,
James
Peoples1,
A. Sue
Menko1,
Kirk
McHugh1, and
Guy
Drolet2
1 Thomas Jefferson University, Department of Pathology,
Anatomy and Cell Biology, Philadelphia, Pennsylvania 19107, and
2 CHUL Research Centre, Neuroscience Unit and Faculté
de Médecine, Université Laval, Québec, Canada G1V4G2
Several biochemical changes have been described in noradrenergic
neurons of the locus coeruleus (LC) after chronic morphine treatment.
Changes in neurochemical expression in opioid afferent projections to
the LC may be equally important in modulating noradrenergic neurons
during chronic opiate exposure. To test the hypothesis that opioid
peptides in LC afferents are altered after chronic opiate
administration, we exposed adult male rats to either morphine or
placebo pellets for 5 d. Tissue sections through the LC were processed for peroxidase or gold-silver labeling of
methionine5-enkephalin (met-ENK) and analyzed
using light or electron microscopy, respectively. Light level
densitometry and ultrastructural analysis showed that there was a
significant decrease in immunolabeling for ENK in LC-afferent terminals
of morphine-treated rats. Western immunoblot analysis confirmed that
protein levels for both leucine5- and
methionine5-ENK were significantly decreased in
tissue samples containing the LC after chronic morphine treatment. To
test whether decreases in ENK protein expression were mirrored by
decreases in gene expression, Northern blot analysis of
preproenkephalin (PPE) mRNA was conducted in tissue samples obtained
through the medulla, a brainstem area that contains the major opioid
afferents to the LC. PPE mRNA was reduced in samples obtained from
morphine-treated rats. Finally, in situ hybridization
experiments confirmed significant decreases in PPE mRNA expression in
the nucleus paragigantocellularis, a region known to provide a robust
opioid input to the LC. These data suggest that there is a decrease in
the synthesis of the opioid peptide mRNA and protein in the
medullo-coerulear pathway after chronic exposure to morphine. Such
alterations in opioid peptide levels during opiate dependence may
contribute to the observed hyperactivity of LC neurons during opiate withdrawal.
Key words:
opioid; noradrenaline; morphine; arousal; enkephalin; opiate withdrawal
Copyright © 2000 Society for Neuroscience 0270-6474/00/20238659-08$05.00/0